USD 15.47
(11.06%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 8.94 Million USD | 16.62% |
2022 | 7.67 Million USD | 24.01% |
2021 | 6.18 Million USD | -21.45% |
2020 | 7.87 Million USD | -25.47% |
2019 | 10.56 Million USD | 44.36% |
2018 | 7.31 Million USD | -94.31% |
2017 | 128.7 Million USD | 108.67% |
2016 | 61.67 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 10.88 Million USD | 15.85% |
2024 Q1 | 9.39 Million USD | 5.02% |
2023 Q4 | 8.94 Million USD | -1.36% |
2023 Q1 | 6.45 Million USD | -15.87% |
2023 Q2 | 7.15 Million USD | 10.93% |
2023 FY | 8.94 Million USD | 16.62% |
2023 Q3 | 9.06 Million USD | 26.68% |
2022 Q2 | 6.3 Million USD | 17.58% |
2022 Q4 | 7.67 Million USD | 5.26% |
2022 FY | 7.67 Million USD | 24.01% |
2022 Q1 | 5.36 Million USD | -13.26% |
2022 Q3 | 7.28 Million USD | 15.52% |
2021 Q1 | 7.08 Million USD | -10.04% |
2021 FY | 6.18 Million USD | -21.45% |
2021 Q4 | 6.18 Million USD | -4.18% |
2021 Q3 | 6.45 Million USD | -3.39% |
2021 Q2 | 6.68 Million USD | -5.68% |
2020 Q4 | 7.87 Million USD | -3.74% |
2020 Q3 | 8.17 Million USD | 14.95% |
2020 FY | 7.87 Million USD | -25.47% |
2020 Q2 | 7.11 Million USD | -17.55% |
2020 Q1 | 8.63 Million USD | -18.31% |
2019 Q4 | 10.56 Million USD | -10.44% |
2019 Q3 | 11.79 Million USD | 34.15% |
2019 Q2 | 8.79 Million USD | -5.76% |
2019 FY | 10.56 Million USD | 44.36% |
2019 Q1 | 9.33 Million USD | 27.5% |
2018 Q3 | 5.02 Million USD | -30.08% |
2018 FY | 7.31 Million USD | -94.31% |
2018 Q1 | 130.1 Million USD | 1.09% |
2018 Q2 | 7.19 Million USD | -94.47% |
2018 Q4 | 7.31 Million USD | 45.51% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | 128.7 Million USD | 0.0% |
2017 FY | 128.7 Million USD | 108.67% |
2016 FY | 61.67 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acutus Medical, Inc. | 54.83 Million USD | 83.689% |
Axonics, Inc. | 82.35 Million USD | 89.139% |
INVO Bioscience, Inc. | 19.99 Million USD | 55.264% |
CVRx, Inc. | 39.28 Million USD | 77.229% |
iRhythm Technologies, Inc. | 223.04 Million USD | 95.99% |
Monogram Orthopaedics, Inc. | 3.18 Million USD | -181.118% |
MaxCyte, Inc. | 36.1 Million USD | 75.226% |
ClearPoint Neuro, Inc. | 21.48 Million USD | 58.372% |
PROCEPT BioRobotics Corporation | 123.96 Million USD | 92.784% |
Sintx Technologies, Inc. | 6.59 Million USD | -35.674% |
Accelerate Diagnostics, Inc. | 51.25 Million USD | 82.548% |
Apyx Medical Corporation | 52.31 Million USD | 82.903% |
Cutera, Inc. | 518.12 Million USD | 98.274% |
Helius Medical Technologies, Inc. | 5.34 Million USD | -67.447% |
NeuroPace, Inc. | 86.99 Million USD | 89.718% |
IRIDEX Corporation | 24.91 Million USD | 64.096% |
Tactile Systems Technology, Inc. | 87.79 Million USD | 89.812% |
enVVeno Medical Corporation | 2.43 Million USD | -267.351% |
TELA Bio, Inc. | 59.16 Million USD | 84.882% |
Tandem Diabetes Care, Inc. | 639.02 Million USD | 98.6% |
UFP Technologies, Inc. | 118.04 Million USD | 92.422% |
Modular Medical, Inc. | 2.27 Million USD | -293.706% |
STRATA Skin Sciences, Inc. | 29.32 Million USD | 69.5% |
LENSAR, Inc. | 22.4 Million USD | 60.083% |
Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.592% |
Surmodics, Inc. | 65.82 Million USD | 86.411% |
Vivos Therapeutics, Inc. | 10.31 Million USD | 13.315% |
Inogen, Inc. | 121.38 Million USD | 92.631% |
Tivic Health Systems, Inc. | 1.67 Million USD | -434.349% |
RxSight, Inc. | 22.18 Million USD | 59.685% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -2003.315% |
Lucid Diagnostics Inc. | 29.58 Million USD | 69.761% |
Nano-X Imaging Ltd. | 23.13 Million USD | 61.334% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -2003.315% |
PetVivo Holdings, Inc. | 2.42 Million USD | -268.213% |
Cytek Biosciences, Inc. | 104.6 Million USD | 91.449% |
Alphatec Holdings, Inc. | 703.48 Million USD | 98.728% |
Rapid Micro Biosystems, Inc. | 25.46 Million USD | 64.871% |
Dynatronics Corporation | 11.78 Million USD | 24.067% |
TriSalus Life Sciences, Inc. | 51.66 Million USD | 82.686% |
InMode Ltd. | 75.91 Million USD | 88.217% |
Bruker Corporation | 2.83 Billion USD | 99.685% |
Movano Inc. | 5.97 Million USD | -49.782% |
Orthofix Medical Inc. | 326.58 Million USD | 97.261% |
FONAR Corporation | 57.45 Million USD | 84.432% |
BioSig Technologies, Inc. | 4.68 Million USD | -90.928% |
Envoy Medical, Inc. | 9.4 Million USD | 4.861% |
Align Technology, Inc. | 2.45 Billion USD | 99.635% |
Anika Therapeutics, Inc. | 58.36 Million USD | 84.675% |
Talis Biomedical Corporation | 29.22 Million USD | 69.392% |
Cerus Corporation | 144.3 Million USD | 93.801% |
908 Devices Inc. | 37.49 Million USD | 76.14% |
Nemaura Medical Inc. | 26.37 Million USD | 66.088% |
Outset Medical, Inc. | 190.91 Million USD | 95.315% |
NanoVibronix, Inc. | 2.68 Million USD | -233.023% |
Venus Concept Inc. | 107.1 Million USD | 91.648% |
Telesis Bio, Inc. | 40.87 Million USD | 78.115% |
Treace Medical Concepts, Inc. | 113.96 Million USD | 92.151% |
Quipt Home Medical Corp. | 136.29 Million USD | 93.437% |
IRadimed Corporation | 20.73 Million USD | 56.862% |
Tenon Medical, Inc. | 5.56 Million USD | -60.679% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -150.42% |
Pulmonx Corporation | 60.63 Million USD | 85.248% |
iCAD, Inc. | 8 Million USD | -11.799% |
QT Imaging Holdings, Inc. | 12.69 Million USD | 29.514% |
NeuroOne Medical Technologies Corporation | 1.84 Million USD | -384.06% |
Viemed Healthcare, Inc. | 40.79 Million USD | 78.071% |
SI-BONE, Inc. | 61.05 Million USD | 85.348% |
Semler Scientific, Inc. | 6.27 Million USD | -42.663% |
Biotricity, Inc. | 35.91 Million USD | 75.097% |
Cytosorbents Corporation | 29.98 Million USD | 70.169% |
DexCom, Inc. | 4.19 Billion USD | 99.787% |
ZimVie Inc. | 795.85 Million USD | 98.876% |
Aethlon Medical, Inc. | 2.47 Million USD | -260.736% |
DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 25.197% |
IceCure Medical Ltd | 4.24 Million USD | -110.619% |
PAVmed Inc | 57.13 Million USD | 84.345% |
Sight Sciences, Inc. | 46.43 Million USD | 80.737% |
Insulet Corporation | 1.85 Billion USD | 99.518% |
Profound Medical Corp. | 12.66 Million USD | 29.377% |
Bioventus Inc. | 589.79 Million USD | 98.483% |
InspireMD, Inc. | 8.14 Million USD | -9.862% |
PAVmed Inc. | 57.13 Million USD | 84.345% |
Nuwellis, Inc. | 6.78 Million USD | -31.932% |
OrthoPediatrics Corp. | 72.56 Million USD | 87.672% |
DIH Holding US, Inc. Warrants | 11.95 Million USD | 25.197% |
BrainsWay Ltd. | 15.31 Million USD | 41.589% |
BIOLASE, Inc. | 35.34 Million USD | 74.694% |
Beyond Air, Inc. | 29.77 Million USD | 69.958% |
AxoGen, Inc. | 101.16 Million USD | 91.158% |
Inari Medical, Inc. | 209.32 Million USD | 95.727% |
Heart Test Laboratories, Inc. | 2.18 Million USD | -309.23% |
Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -402.811% |
AdaptHealth Corp. | 3.15 Billion USD | 99.716% |
Quanterix Corporation | 78.08 Million USD | 88.544% |
Viveve Medical, Inc. | 10.84 Million USD | 17.535% |
LivaNova PLC | 1.15 Billion USD | 99.223% |
Co-Diagnostics, Inc. | 17.63 Million USD | 49.274% |
Varex Imaging Corporation | 668.6 Million USD | 98.662% |
Vivani Medical, Inc. | 25.03 Million USD | 64.271% |
ReShape Lifesciences Inc. | 4.06 Million USD | -120.103% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -150.42% |
Sensus Healthcare, Inc. | 4.88 Million USD | -83.112% |
Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.144% |
TransMedics Group, Inc. | 568.84 Million USD | 98.428% |
ReWalk Robotics Ltd. | 16.68 Million USD | 46.379% |
NeuroMetrix, Inc. | 1.33 Million USD | -570.98% |
Spectral AI, Inc. | 12.4 Million USD | 27.869% |
Hyperfine, Inc. | 9.8 Million USD | 8.724% |
Establishment Labs Holdings Inc. | 250.24 Million USD | 96.426% |
Biomerica, Inc. | 2.66 Million USD | -235.899% |
Bone Biologics Corporation | 831.4 Thousand USD | -975.893% |
AVITA Medical, Inc. | 19.86 Million USD | 54.972% |
Bluejay Diagnostics, Inc. | 1.97 Million USD | -353.214% |
Silk Road Medical, Inc | 114.15 Million USD | 92.164% |